Dottikon Es Holding AG logo

DESN - Dottikon Es Holding AG News Story

CHF181 -2.0  -1.1%

Last Trade - 9:05am

Sector
Healthcare
Size
Mid Cap
Market Cap £1.97bn
Enterprise Value £1.92bn
Revenue £147.4m
Position in Universe 303rd / 1050

Swiss stocks - Factors to watch on April 21

Fri 21st April, 2017 6:21am
ZURICH, April 21 (Reuters) - The following are some of the 
main factors expected to affect Swiss stocks on Friday: 
     
    COMPANY STATEMENTS  CPR-CH  
    * Banking software supplier Temenos  TEMN.S  confirmed its 
full-year guidance after growing revenues by 13 percent in the 
first quarter of 2017, according to non-IFRS reporting standards 
and a constant-currency basis, and earnings before interest and 
tax 15 percent to 27.3 million Swiss francs.  TEMN.S  
    * SHL Telemedicine  SHLTN.S  said its board had resolved 
today to appoint Yoav Rubinstein as an interim acting CEO and 
Yossi Vadnagra as interim acting CFO.  SHLTN.S  
    * Basilea Pharmaceutica  BSLN.S  said it has reached 
agreement with the U.S. Food and Drug Administration (FDA) on 
Special Protocol Assessments (SPAs) for its two planned phase 3 
clinical studies of Basilea's antibiotic ceftobiprole.  BSLN.S  
    * Dottikon Holding  DESN.S  said it's ceasing its 
third-party solvent recycling business in the second half of 
2017. Extraordinary effects will bring down full-year 2016/17 
results by around 5 million francs, the group said, but Dottikon 
still expects an increase in net sales and net income 
year-on-year for the year ended March 31.  DESN.S  
    * BB Biotech  BION.S  expects significant cash in the second 
quarter from Johnson & Johnson's  JNJ.N  acquisition of Actelion 
 ATLN.S . The biotech investment company reported bottom-line 
profit of 375 million francs in the first quarter of 2017 as its 
portfolio generated returns of 7.7 percent in francs and 7.1 
percent in euros.  BION.S  
    * Panalpina Welttransport Holding  PWTN.S  posted 
first-quarter consolidated profit of 12.4 million francs 
compared to 17.3 million francs a year earlier.  PWTN.S  
    * Inficon Holding AG  IFCN.S  said first-quarter operating 
income more than doubled to $17.8 million. It maintained its 
guidance for the full year 2017, expecting sales of over $320 
million and an operating income margin exceeding 17 percent. 
 IFCN.S  
   
    ECONOMY  M-CH  
 
 
 (Reporting by Zurich newsroom) 
 ((+41 58 306 7336)(zurich.newsroom@thomsonreuters.com)) 
  
((For Top News in a multimedia Web format on Eikon visit: 
https://emea1.views.cp.extranet.thomsonreuters.biz/Explorer/NEWSxTOPNEWS.aspx?group=SP_GROUP_001&page=SP_PAGE_001&pageName=FrontPage 
 FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON: 
     
 Daily Swiss stock market report in German................ .SDE  
 All SMI constituent stocks............................ 0#.SSMI   
 News on major Swiss stock price moves.................. CH-HOT  
 FTSE Eurotop 300 index................................  .FTEU3  
 DJ STOXX index........................................  .STOXX  
 Top 10 STOXX sectors.............................  .PGL.STOXXS   
 Top 10 EUROSTOXX sectors........................  .PGL.STOXXES  
 Top 10 Eurotop 300 sectors.......................  .PGL.FTEU3S  
 Top 25 European pct gainers...  .PG.PEUR , losers...  .PL.PEUR  
     
 Swiss mid-cap index      .SSMI   SMI futures            0#SMI:  
 Swiss all-share index    .SSHI   Market statistics   CH/STATS1  
 Swiss market digest      .AD.S   Sector overview    CH/SECTOR1  
 All Swiss news              CH   Swiss research news     CH-RCH    
 All equity news              E   
      
 INTERNET ADDRESSES:               
  
Swiss Exchange  www.swx.ch/      
Eurex   www.eurexchange.com 
STOXX Ltd         www.stoxx.com  
  
 SPEED GUIDES:  VX/EQUITY   EQUITY   EQUITY/NEWS1   EUR/EQUITY   
  SWITZERLAND   REUTERS  )) 
 
Keywords: MARKETS SWISS STOCKS/
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.